GAVI Alliance has initiated a $1 billion programme for African Vaccine Manufacturing Accelerator (AVMA) to boost its production in Africa. AVMA is a financial instrument that addresses inequality in access to vaccines, as witnessed during the COVID-19 pandemic.
Chief Executive Officer at GAVI, Sania Nishtar, who disclosed this at the weekend when the Executive Director of the National Primary Healthcare Development Agency (NPHCDA), Dr. Muyiwa Aina, led the GAVI team on a visit to the centre in Mabuchi, advised that Nigeria needed to have a right institutional environment with regulatory capacity.
She added that the most populous nation must create an investment environment for investors to contribute meaningfully.
In his remarks, NPHCDA’s Executive Director, Dr. MuyiwaAina, said the government was working round the clock to save children from vaccine-preventable diseases.
